BlackRock, Inc. 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
5,705,051 5.500% |
385,872 (+7.25%) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
5,319,179 5.600% |
327,892 (+6.57%) |
Filing |
| 2022-08-09 4:02 pm Sale |
2022-07-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
4,991,287 5.300% |
-5,236,386 (-51.20%) |
Filing |
| 2022-05-09 3:23 pm Purchase |
2022-04-30 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
10,227,673 10.900% |
2,209,039 (+27.55%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
8,018,634 8.800% |
2,855,614 (+55.31%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
5,163,020 6.400% |
5,163,020 (New Position) |
Filing |